Healthcare -
Biotechnology - NASDAQ - US
$ 1.09
-0.909 %
$ 227 M
Market Cap
-1.54
P/E
SGMO - OTHER LONG-TERM ASSETS
Other Long-term Assets SGMO - Sangamo Therapeutics, Inc.
18.1 M
LAST VALUE
33.48%
2 YEAR CAGR
23.77%
5 YEAR CAGR
84.34%
10 YEAR CAGR